Research Article
BibTex RIS Cite

Year 2020, Volume: 24 Issue: 1, 30 - 37, 27.06.2025

Ahmet Serhat Ekinci Jan Moncol Siva Krishna Vagolu , Sriram Dharmarajan , Keriman Ozadalı Sarı

https://doi.org/10.35333/jrp.2020.110
Cited By: 5

Abstract

References

  • [1] WHO Global tuberculosis report 2018. https://www.who.int/tb/publications/global_report/en/, (accessed October 02, 2019).
  • [2] Jonas da Silva S, Joel Jones J, Flavia MdS. 1,3-Thiazolidin-4-ones: Biological potential, history, synthetic development and green methodologies. Curr Org Synth. 2018; 15(8): 1109-1123. [CrossRef]
  • [3] Ekinci D, Fidan İ, Durdagi S, Kaban Ş, Supuran CT. Kinetic and in silico analysis of thiazolidin-based inhibitors of α-carbonic anhydrase isoenzymes. J Enzym Inhib Med Ch. 2013; 28(2): 370-374. [CrossRef]
  • [4] Tripathi AC, Gupta SJ, Fatima GN, Sonar PK, Verma A, Saraf SK. 4-Thiazolidinones: The advances continue…. Eur J Med Chem. 2014; 72: 52-77. [CrossRef]
  • [5] Raza S, Srivastava SP, Srivastava DS, Srivastava AK, Haq W, Katti SB. Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents. Eur J Med Chem. 2013; 63: 611-620. [CrossRef]
  • [6] Verma A, Saraf SK. 4-Thiazolidinone–A biologically active scaffold. Eur J Med Chem. 2008; 43(5): 897-905. [CrossRef]
  • [7] Chitre TS, Asgaonkar KD, Miniyar PB, Dharme AB, Arkile MA, Yeware A, et al. Synthesis and docking studies of pyrazine–thiazolidinone hybrid scaffold targeting dormant tuberculosis. Bioorg Med Chem Lett. 2016; 26(9): 2224- 2228. [CrossRef]
  • [8] Güzel Ö, Salman A. Synthesis and biological evaluation of new 4-thiazolidinone derivatives. J Enzym Inhib Med Ch. 2009; 24(4): 1015-1023. [CrossRef]
  • [9] Bhat MA. Synthesis and anti-mycobacterial activity of new 4-thiazolidinone and 1,3,4-oxadiazole derivatives of isoniazid. Acta Pol Pharm. 2014; 71(5): 763-770.
  • [10] Tejeswara Rao A, Naresh Kumar K, Venkanna B, Srinubabu M, Manojit P, Jaya Shree A. Synthesis and antibacterial/antitubercular/antioxidant activities of compounds containing fluoroquinolone ring linked to a 4- thiazolidinone moiety. Lett Drug Des Discov. 2018; 15(10): 1087-1094. [CrossRef]
  • [11] Deshmukh AR, Dhumal ST, Nawale LU, Khedkar VM, Sarkar D, Mane RA. Dicationic liquid mediated synthesis of tetrazoloquinolinyl methoxy phenyl 4-thiazolidinones and their antibacterial and antitubercular evaluation. Synthetic Commun. 2019; 49(4): 587-601. [CrossRef]
  • [12] Jaju S, Palkar M, Maddi V, Ronad P, Mamledesai S, Satyanarayana D, et al. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives. Arch Pharm. 2009; 342(12): 723-731. [CrossRef]
  • [13] El Bialy SA, Nagy MM, Abdel-Rahman HM. Efficient regioselective three-component domino synthesis of 3-(1,2,4- triazol-5-yl)-1,3-thiazolidin-4-ones as potent antifungal and antituberculosis agents. Arch Pharm. 2011; 344(12): 821- 829. [CrossRef]
  • [14] Cihan-Üstündağ G, Şatana D, Özhan G, Çapan G. Indole-based hydrazide-hydrazones and 4-thiazolidinones: synthesis and evaluation as antitubercular and anticancer agents. J Enzym Inh Med Ch. 2016; 31(3): 369-380. [CrossRef]
  • [15] Unsal-Tan O, Ozadali K, Piskin K, Balkan A. Molecular modeling, synthesis and screening of some new 4- thiazolidinone derivatives with promising selective COX-2 inhibitory activity. Eur J Med Chem. 2012; 57: 59-64. [CrossRef]
  • [16] Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JAK, Puschmann H. OLEX2: a complete structure solution, refinement and analysis program. J Appl Crystallogr. 2009; 42(2): 339-341. [CrossRef]
  • [17] Sheldrick G. SHELXT-Integrated space-group and crystal-structure determination. Acta Crystall A. 2015; 71(1): 3-8. [CrossRef]
  • [18] Sheldrick G. Crystal structure refinement with SHELXL. Acta Crystall C. 2015;71(1):3-8. [CrossRef]
  • [19] Nagalakshmi G, Maity T, Maiti B. Synthesis, characterization and anti-HIV evaluation of some novel 2- (substitutedphenyl)-5-methyl-3-(phenylamino)-1,3-thiazolidin-4-ones. Int J Chem Tech Res. 2013; 5(5): 2068-2078.
  • [20] Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Ch. 1997; 41(5): 1004-1009. [CrossRef]

5-Methyl-4-thiazolidinones: Synthesis and evaluation as antitubercular agents

Year 2020, Volume: 24 Issue: 1, 30 - 37, 27.06.2025

Ahmet Serhat Ekinci Jan Moncol Siva Krishna Vagolu , Sriram Dharmarajan , Keriman Ozadalı Sarı

https://doi.org/10.35333/jrp.2020.110
Cited By: 5

Abstract

This paper reports the synthesis, characterization and evaluation of some 5-methyl-4-thiazolidinone derivatives for their in vitro antimycobacterial activities against Mycobacterium tuberculosis H37Rv strain by microplate alamar blue assay. Also the crystal structures of the compounds (2a and 2c) were determined by the single-crystal Xray diffraction study. Among the target compounds, 2-(4-ethoxyphenyl)-5-methyl-3-(phenylamino)thiazolidin-4-one (2g) was promising with a minimum inhibitory concentration of 12.5 μg/mL against M. tuberculosis. Based on the preliminary results, 2g was considered as a lead compound for further optimization of antimycobacterial activity.

Keywords

Antimycobacterial tuberculosis 4-thiazolidinone single-crystal X-ray diffraction

References

  • [1] WHO Global tuberculosis report 2018. https://www.who.int/tb/publications/global_report/en/, (accessed October 02, 2019).
  • [2] Jonas da Silva S, Joel Jones J, Flavia MdS. 1,3-Thiazolidin-4-ones: Biological potential, history, synthetic development and green methodologies. Curr Org Synth. 2018; 15(8): 1109-1123. [CrossRef]
  • [3] Ekinci D, Fidan İ, Durdagi S, Kaban Ş, Supuran CT. Kinetic and in silico analysis of thiazolidin-based inhibitors of α-carbonic anhydrase isoenzymes. J Enzym Inhib Med Ch. 2013; 28(2): 370-374. [CrossRef]
  • [4] Tripathi AC, Gupta SJ, Fatima GN, Sonar PK, Verma A, Saraf SK. 4-Thiazolidinones: The advances continue…. Eur J Med Chem. 2014; 72: 52-77. [CrossRef]
  • [5] Raza S, Srivastava SP, Srivastava DS, Srivastava AK, Haq W, Katti SB. Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents. Eur J Med Chem. 2013; 63: 611-620. [CrossRef]
  • [6] Verma A, Saraf SK. 4-Thiazolidinone–A biologically active scaffold. Eur J Med Chem. 2008; 43(5): 897-905. [CrossRef]
  • [7] Chitre TS, Asgaonkar KD, Miniyar PB, Dharme AB, Arkile MA, Yeware A, et al. Synthesis and docking studies of pyrazine–thiazolidinone hybrid scaffold targeting dormant tuberculosis. Bioorg Med Chem Lett. 2016; 26(9): 2224- 2228. [CrossRef]
  • [8] Güzel Ö, Salman A. Synthesis and biological evaluation of new 4-thiazolidinone derivatives. J Enzym Inhib Med Ch. 2009; 24(4): 1015-1023. [CrossRef]
  • [9] Bhat MA. Synthesis and anti-mycobacterial activity of new 4-thiazolidinone and 1,3,4-oxadiazole derivatives of isoniazid. Acta Pol Pharm. 2014; 71(5): 763-770.
  • [10] Tejeswara Rao A, Naresh Kumar K, Venkanna B, Srinubabu M, Manojit P, Jaya Shree A. Synthesis and antibacterial/antitubercular/antioxidant activities of compounds containing fluoroquinolone ring linked to a 4- thiazolidinone moiety. Lett Drug Des Discov. 2018; 15(10): 1087-1094. [CrossRef]
  • [11] Deshmukh AR, Dhumal ST, Nawale LU, Khedkar VM, Sarkar D, Mane RA. Dicationic liquid mediated synthesis of tetrazoloquinolinyl methoxy phenyl 4-thiazolidinones and their antibacterial and antitubercular evaluation. Synthetic Commun. 2019; 49(4): 587-601. [CrossRef]
  • [12] Jaju S, Palkar M, Maddi V, Ronad P, Mamledesai S, Satyanarayana D, et al. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives. Arch Pharm. 2009; 342(12): 723-731. [CrossRef]
  • [13] El Bialy SA, Nagy MM, Abdel-Rahman HM. Efficient regioselective three-component domino synthesis of 3-(1,2,4- triazol-5-yl)-1,3-thiazolidin-4-ones as potent antifungal and antituberculosis agents. Arch Pharm. 2011; 344(12): 821- 829. [CrossRef]
  • [14] Cihan-Üstündağ G, Şatana D, Özhan G, Çapan G. Indole-based hydrazide-hydrazones and 4-thiazolidinones: synthesis and evaluation as antitubercular and anticancer agents. J Enzym Inh Med Ch. 2016; 31(3): 369-380. [CrossRef]
  • [15] Unsal-Tan O, Ozadali K, Piskin K, Balkan A. Molecular modeling, synthesis and screening of some new 4- thiazolidinone derivatives with promising selective COX-2 inhibitory activity. Eur J Med Chem. 2012; 57: 59-64. [CrossRef]
  • [16] Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JAK, Puschmann H. OLEX2: a complete structure solution, refinement and analysis program. J Appl Crystallogr. 2009; 42(2): 339-341. [CrossRef]
  • [17] Sheldrick G. SHELXT-Integrated space-group and crystal-structure determination. Acta Crystall A. 2015; 71(1): 3-8. [CrossRef]
  • [18] Sheldrick G. Crystal structure refinement with SHELXL. Acta Crystall C. 2015;71(1):3-8. [CrossRef]
  • [19] Nagalakshmi G, Maity T, Maiti B. Synthesis, characterization and anti-HIV evaluation of some novel 2- (substitutedphenyl)-5-methyl-3-(phenylamino)-1,3-thiazolidin-4-ones. Int J Chem Tech Res. 2013; 5(5): 2068-2078.
  • [20] Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Ch. 1997; 41(5): 1004-1009. [CrossRef]
There are 20 citations in total.

Details

Primary Language English
Subjects Pharmaceutical Chemistry
Journal Section Articles
Authors

Ahmet Serhat Ekinci

Jan Moncol

Siva Krishna Vagolu

Sriram Dharmarajan

Keriman Ozadalı Sarı

Publication Date June 27, 2025
Published in Issue Year 2020 Volume: 24 Issue: 1

Cite

APA Ekinci, A. S., Moncol, J., Vagolu, S. K., Dharmarajan, S., et al. (2025). 5-Methyl-4-thiazolidinones: Synthesis and evaluation as antitubercular agents. Journal of Research in Pharmacy, 24(1), 30-37. https://doi.org/10.35333/jrp.2020.110
AMA Ekinci AS, Moncol J, Vagolu SK, Dharmarajan S, Ozadalı Sarı K. 5-Methyl-4-thiazolidinones: Synthesis and evaluation as antitubercular agents. J. Res. Pharm. June 2025;24(1):30-37. doi:10.35333/jrp.2020.110
Chicago Ekinci, Ahmet Serhat, Jan Moncol, Siva Krishna Vagolu, Sriram Dharmarajan, and Keriman Ozadalı Sarı. “5-Methyl-4-Thiazolidinones: Synthesis and Evaluation As Antitubercular Agents”. Journal of Research in Pharmacy 24, no. 1 (June 2025): 30-37. https://doi.org/10.35333/jrp.2020.110.
EndNote Ekinci AS, Moncol J, Vagolu SK, Dharmarajan S, Ozadalı Sarı K (June 1, 2025) 5-Methyl-4-thiazolidinones: Synthesis and evaluation as antitubercular agents. Journal of Research in Pharmacy 24 1 30–37.
IEEE A. S. Ekinci, J. Moncol, S. K. Vagolu, S. Dharmarajan, and K. Ozadalı Sarı, “5-Methyl-4-thiazolidinones: Synthesis and evaluation as antitubercular agents”, J. Res. Pharm., vol. 24, no. 1, pp. 30–37, 2025, doi: 10.35333/jrp.2020.110.
ISNAD Ekinci, Ahmet Serhat et al. “5-Methyl-4-Thiazolidinones: Synthesis and Evaluation As Antitubercular Agents”. Journal of Research in Pharmacy 24/1 (June 2025), 30-37. https://doi.org/10.35333/jrp.2020.110.
JAMA Ekinci AS, Moncol J, Vagolu SK, Dharmarajan S, Ozadalı Sarı K. 5-Methyl-4-thiazolidinones: Synthesis and evaluation as antitubercular agents. J. Res. Pharm. 2025;24:30–37.
MLA Ekinci, Ahmet Serhat et al. “5-Methyl-4-Thiazolidinones: Synthesis and Evaluation As Antitubercular Agents”. Journal of Research in Pharmacy, vol. 24, no. 1, 2025, pp. 30-37, doi:10.35333/jrp.2020.110.
Vancouver Ekinci AS, Moncol J, Vagolu SK, Dharmarajan S, Ozadalı Sarı K. 5-Methyl-4-thiazolidinones: Synthesis and evaluation as antitubercular agents. J. Res. Pharm. 2025;24(1):30-7.

Cited By

Antimycobacterial Assessment and Microwave-assisted Synthesis of 2-aryl- 3-(4-methylphenylamino)thiazolidin-4-one Derivatives
Letters in Organic Chemistry
https://doi.org/10.2174/1570178618666210302160625
Crystal structure of (E)-3-(benzylideneamino)-2-phenylthiazolidin-4-one, C16H14N2OS
Zeitschrift für Kristallographie - New Crystal Structures
https://doi.org/10.1515/ncrs-2023-0518
Studies of thermal, spectral and antibacterial activities of some inclusion complexes of 4-Thiazolidinone derivatives with β-Cyclodextrin
Asian Journal of Research in Chemistry
https://doi.org/10.52711/0974-4150.2022.00010
Quantitative structure activity relationship (QSAR) modeling study of some novel thiazolidine 4-one derivatives as potent anti-tubercular agents
Journal of Receptors and Signal Transduction
https://doi.org/10.1080/10799893.2023.2281671
Design, Synthesis, and Molecular Docking Studies of Some New Quinoxaline Derivatives as EGFR Targeting Agents
Russian Journal of Bioorganic Chemistry
https://doi.org/10.1134/S1068162022030220